Squamous Cell Carcinoma Developing in a Buccal Mucosa Graft after Urethroplasty: A Report of 2 Cases of Malignant Degeneration.
| Autor: | Massimo C; Paediatric Urology, Città Della Salute e Della Scienza Torino, Italy., Simona NG; Paediatric Urology, Città Della Salute e Della Scienza Torino, Italy., Barbara T; Paediatric Urology, Città Della Salute e Della Scienza Torino, Italy., Elisa C; Paediatric Urology, Città Della Salute e Della Scienza Torino, Italy., Luisa F; Paediatric Urology, Città Della Salute e Della Scienza Torino, Italy., Alessandro G; Pathology Unit, Department of Medical Sciences, Città Della Salute e Della Scienza Torino, Italy., Donatella P; Pathology Unit, Città Della Salute e Della Scienza Torino, Italy., Teruzzi E; Paediatric Urology, Città Della Salute e Della Scienza Torino, Italy., Falcone M; Urology Department, Città Della Salute e Della Scienza Torino, Italy., Omidreza S; Urology Department, Città Della Salute e Della Scienza Torino, Italy., Paolo G; Urology Department, Città Della Salute e Della Scienza Torino, Italy. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Case reports in urology [Case Rep Urol] 2021 Jul 24; Vol. 2021, pp. 5569373. Date of Electronic Publication: 2021 Jul 24 (Print Publication: 2021). |
| DOI: | 10.1155/2021/5569373 |
| Abstrakt: | Buccal mucosa graft (BMG) was originally described in 1992 for the treatment of challenging cases of hypospadias (proximal or redo cases) and has gained increasingly popularity also when dealing with complicated urethral stenosis, as it is associated with a good outcome. The development of a malignancy in a BMG urethroplasty was reported for the first time in 2017. We report two more cases of a malignant degeneration of a BMG used in a urethroplasty to treat recurrent urethral stricture. Competing Interests: The authors declare that they have no conflicts of interest. (Copyright © 2021 Catti Massimo et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|